Compare Bio Protocol (BIO) vs STBL (STBL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs STBL — how do they compare? Bio Protocol trades at Rp515.63 (market cap Rp1,15T, Rp260,42M 24h volume), while STBL trades at Rp410.01 (market cap Rp287,36M, Rp41,54M 24h volume). The key difference: Bio Protocol is far larger — about 4001.9× STBL's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 700M / 10B STBL (8%) for STBL. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and STBL for 7 Days on average.
| BIO | STBL | |
|---|---|---|
Market Cap | Rp1,15T | Rp287,36M |
Volume (24h) | Rp260,42M | Rp41,54M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 700M / 10B STBL (8%) |
Typical Hold Time | 16 Days | 7 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
STBL is currently trading at Rp413.766 with a market cap of Rp291.37M, showing bearish technical signals across most indicators. The asset faces selling pressure with moving averages indicating strong bearish momentum while oscillators remain neutral. With only 8% of the maximum 10M supply in circulation and short 7-day average hold time, the token shows limited distribution but high turnover.
Overall outlook remains cautious with technical weakness outweighing neutral fundamentals. Key opportunities include potential rebound from support levels, while major risks include low liquidity, high volatility, and limited network adoption. Investors should monitor trading volume and ecosystem developments closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About STBL
STBL is a decentralized stablecoin protocol that separates real-world asset collateral into a spendable stablecoin (USST) and a yield-bearing NFT (YLD), governed by the STBL token. Its three-token architecture distinguishes liquidity, yield, and governance functions. Backed by tokenized Treasuries and money market funds, the protocol emphasizes transparency and community-driven decision-making.
Read more on STBL →
